Guidelines for the Quality Control of Population Pharmacokinetic-Pharmacodynamic Analyses: an Industry Perspective

被引:25
|
作者
Bonate, P. L. [1 ]
Strougo, A. [2 ]
Desai, A. [1 ]
Roy, M. [1 ]
Yassen, A. [2 ]
van der Walt, J. S. [2 ]
Kaibara, A. [3 ]
Tannenbaum, S. [1 ]
机构
[1] Astellas Pharma Global Dev, Northbrook, IL 60062 USA
[2] Astellas Pharma Global Dev, NL-2353W Leiderdorp, Netherlands
[3] Astellas Pharma Inc, Itabashi Ku, Tokyo 1748612, Japan
来源
AAPS JOURNAL | 2012年 / 14卷 / 04期
关键词
modeling; NONMEM; quality assurance; VALIDATION; MODEL;
D O I
10.1208/s12248-012-9387-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Quality population modeling and simulation analyses and reports are something every modeler desires. However, little attention in the literature has been paid to what constitutes quality regarding population analyses. Very rarely do published manuscripts contain any statement about quality assurance of the modeling results contained therein. The purpose of this manuscript is to present guidelines for the quality assurance of population analyses, particularly with regards to the use of NONMEM from an industrial perspective. Quality guidelines are developed for the NONMEM installation itself, NONMEM data sets, control streams, output listings, output data files and resultant post-processing, reporting of results, and the review processes. These guidelines were developed to be thorough yet practical, though are not meant to be completely comprehensive. It is our desire to ensure that what is reported accurately reflects the collected data, the modeling process, and model outputs for a modeling project.
引用
收藏
页码:749 / 758
页数:10
相关论文
共 50 条
  • [41] Reporting guidelines for population pharmacokinetic analyses
    Dykstra, Kevin
    Mehrotra, Nitin
    Tornoe, Christoffer Wenzel
    Kastrissios, Helen
    Patel, Bela
    Al-Huniti, Nidal
    Jadhav, Pravin
    Wang, Yaning
    Byon, Wonkyung
    JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 55 (08): : 875 - 887
  • [42] Reporting guidelines for population pharmacokinetic analyses
    Dykstra, Kevin
    Mehrotra, Nitin
    Tornoe, Christoffer Wenzel
    Kastrissios, Helen
    Patel, Bela
    Al-Huniti, Nidal
    Jadhav, Pravin
    Wang, Yaning
    Byon, Wonkyung
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2015, 42 (03) : 301 - 314
  • [43] Translational pharmacokinetic-pharmacodynamic analysis in the pharmaceutical industry: an IQ Consortium PK-PD Discussion Group perspective
    Wong, Harvey
    Bohnert, Tonika
    Damian-Lordache, Valeriu
    Gibson, Christopher
    Hsu, Cheng-Pang
    Krishnatry, Anu Shilpa
    Liederer, Bianca M.
    Lin, Jing
    Lu, Qiang
    Mettetal, Jerome T.
    Mudra, Daniel R.
    Nijsen, Marjoleen J. M. A.
    Schroeder, Patricia
    Schuck, Edgar
    Suryawanshi, Satyendra
    Trapa, Patrick
    Tsai, Alice
    Wang, Haiqing
    Wus, Fan
    DRUG DISCOVERY TODAY, 2017, 22 (10) : 1447 - 1459
  • [44] Population Pharmacokinetic-Pharmacodynamic Model of Serum Transthyretin Following Patisiran Administration
    Goel, Varun
    Gosselin, Nathalie H.
    Jomphe, Claudia
    Zhang, Xiaoping
    Marier, Jean-Francois
    Robbie, Gabriel J.
    NUCLEIC ACID THERAPEUTICS, 2020, 30 (03) : 143 - 152
  • [45] Pharmacokinetic-Pharmacodynamic Modelling of Recombinant Human Erythropoietin in AthletesA Population Approach
    A. Gaudard
    E. Varlet-Marie
    M. Audran
    R. Gomeni
    F. Bressolle
    Clinical Drug Investigation, 2003, 23 : 167 - 179
  • [46] Population Pharmacokinetic-Pharmacodynamic Modeling of 5-Fluorouracil for Toxicities in Rats
    Kobuchi, Shinji
    Ito, Yukako
    Sakaeda, Toshiyuki
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2017, 42 (04) : 707 - 718
  • [47] Comparative population pharmacokinetic-pharmacodynamic analysis for piroxicam-β-cyclodextrin and piroxicam
    Wang, D
    Miller, R
    Zheng, J
    Hu, CP
    JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 40 (11): : 1257 - 1266
  • [48] Population pharmacokinetic-pharmacodynamic modelling of angiotensin receptor blockade in healthy volunteers
    Csajka, C
    Buclin, T
    Fattinger, K
    Brunner, HR
    Biollaz, J
    CLINICAL PHARMACOKINETICS, 2002, 41 (02) : 137 - 152
  • [49] Population pharmacokinetic-pharmacodynamic analysis for eribulin mesilate-associated neutropenia
    van Hasselt, J. G. Coen
    Gupta, Anubha
    Hussein, Ziad
    Beijnen, Jos H.
    Schellens, Jan H. M.
    Huitema, Alwin D. R.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 76 (03) : 412 - 424
  • [50] Population Pharmacokinetic-Pharmacodynamic Modelling of Angiotensin Receptor Blockade in Healthy Volunteers
    Chantal Csajka
    Thierry Buclin
    Karin Fattinger
    Hans R. Brunner
    Jérôme Biollaz
    Clinical Pharmacokinetics, 2002, 41 : 137 - 152